Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: A prospective multicenter study

Clinical Infectious Diseases

Volumn 49, Issue 6, 2009, Pages 931-934

  Sungkanuparph, Somnuek ^a,m   Filler, Scott G ^f   Chetchotisakd, Ploenchan ^c   Pappas, Peter G ⁱ   Nolen, Tracy L ^l   Manosuthi, Weerawat ^d   Anekthananon, Thanomsak ^b   Morris, Michèle I ^h   Supparatpinyo, Khuanchai ^e   Kopetskie, Heather ^l   Kendrick, Amy S ^l   Johnson, Philip C ^j   Sobel, Jack D ^k   Larsen, Robert A ^g  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c KHON KAEN UNIVERSITY   (Thailand)

^d Bamrasnaradura Infectious Diseases Institute   (Thailand)

^e Faculty of Medicine Chiang Mai University   (Thailand)

^f HARBOR UCLA MEDICAL CENTER   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j UNIVERSITY OF TEXAS   (United States)

^k WAYNE STATE UNIVERSITY   (United States)

^l Federal Systems Division Rho   (United States)

^m MAHIDOL UNIVERSITY   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; CRYPTOCOCCAL MENINGITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; PRIORITY JOURNAL; RISK FACTOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTI-HIV AGENTS; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CLINICAL TRIALS, PHASE II AS TOPIC; FLUCONAZOLE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOCOMPROMISED HOST; INCIDENCE; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MENINGITIS, CRYPTOCOCCAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TIME FACTORS;

EID: 70049116229     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605497     Document Type: Article

References (13)

1. Kambugu A, Meya DB, Rhein J, et al. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis 2008;46:1694-1701 (Pubitemid 351706766)
2. Jongwutiwes U, Kiertiburanakul S, Sungkanuparph S. Impact of antiretroviral therapy on the relapse of cryptococcosis and survival of HIVinfected patients with cryptococcal infection. Curr HIV Res 2007; 5: 355-360 (Pubitemid 46785072)
3. French MA, Price P, Stone SE Immune restoration disease after antiretroviral therapy. AIDS 2004;18:1615-1627 (Pubitemid 39095778)
4. French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunodefident HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000;1:107-115
5. Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis 2004;38:1159-1166
6. Race EM., Adelson-Mitty J, Kriegel GR, et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-I disease. Lancet 1998;351:252-255 (Pubitemid 28043950)
7. Sungkanuparph S, Vibhagool A, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C. Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis. AIDS 2003;17:2129-2131 (Pubitemid 37297165)
8. Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES, Chan RM. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 2000;30:882-892
9. Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis 2002; 35:e128-33.
10. Lortholary O, Fontanet A, Mémain N, et al. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIVassociated cryptococcosis in France. AIDS 2005;19:1043-1049 (Pubitemid 40961144)
11. Shelburne SA III, Darcourt J, White AC Jr, et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005;40:1049-1052
12. Sungkanuparph S, Jongwutiwes U, Kiertiburanakul S. Timing of cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in patients with AIDS and cryptococcal meningitis. J Acquir Immune Defic Syndr 2007;45:595-596 (Pubitemid 47294935)
13. Pappas PG, Chetchotisakd P, Larsen RA, et al. A phase II trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis 2009;48: 1775-1783